Liquid biopsy 2025 Top Key players by: Illumina, Inc., Bio-Rad Laboratories Inc., Myriad Genetics, Inc., Menarini Silicon Biosystems, Genomic Health, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., Biocept, Inc., Trovagene, Inc., RainDance Technologies,

Liquid biopsy is a non-invasive alternative of surgical biopsies that has enabled the doctors to analyse various chronic tumors with the help of blood sample. This technique analyses the trace of cancer of cancer cell in the blood sample at an initial stage for proper treatment. The commonly used techniques in this market is ctDNA known as Circulating tumor DNA, which is used according to the patient’s condition.

The Liquid Biopsy market is expected to reach USD 3,051.1 million by 2025, at a CAGR of 14.9%.

Request for Free Sample Report @ https://www.polarismarketresearch.com/industry-analysis/liquid-biopsy-market/request-for-free-sample

The liquid biopsy market to witness a positive growth owning to the factors such as increasing consumer preference for non-invasive techniques of diagnosis, and rising number of cancer patients across the globe. Additionally, a smaller number of trails and clinical sittings for the diagnosis of cancer, and accurate genomic snapshot of the patient to also influence the market growth during the forecast period. Furthermore, increasing number of biopharmaceutical industries that focus on liquid biopsy, and rising number of merger and acquisition between the key players in the untapped market to boost the liquid biopsy market growth in the coming years. However, stringent government policies and high price of this technique would impede the market growth.

Major Key Player: -

Roche Diagnostics
Illumina Inc.
Bio-Rad Laboratories Inc.
Myriad Genetics Inc.
Menarini Silicon Biosystems
Genomic Health Inc.
QIAGEN N.V.
Thermo Fisher Scientific Inc.
Biocept Inc.
Trovagene, Inc.
RainDance Technologies Inc.
Guardant Health, Inc.
MDx Health SA.

The report provides an extensive qualitative and quantitative analysis of the market trends and growth prospects of the Global Liquid Biopsy Market, 2017-2025. This report comprises a detailed geographic distribution of the market across North America, Europe, Asia-Pacific, Latin America, and MEA. North America is further segmented into U.S., Canada, and Mexico. Europe is divided into Germany, UK, Italy, France, and Rest of Europe. Asia-Pacific is bifurcated into China, India, Japan, and Rest of Asia-Pacific.

Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.polarismarketresearch.com/industry-analysis/liquid-biopsy-market/speak-to-analyst

North America generated the highest revenue in 2017 in the liquid biopsy market owing to the growing medical industry, and growing awareness for providing quality diagnosis for the patients, and rising accessibility to the patients for various types of cancer. Moreover, increasing number of patients suffering from cancer owning to the changing lifestyle to also support the market growth in coming years. While, Asia Pacific is estimated to be the fastest growing market owning to the continuous changing healthcare industry in the developing countries.

Read More For Details: https://www.polarismarketresearch.com/industry-analysis/liquid-biopsy-market/

Competitive Landscape

The global liquid biopsy market is characterized by the presence of well-diversified international and small and medium-sized vendors. These companies are consistently launching new products to enhance their offerings in the market. With the advancement of technologies, companies are innovating and introducing new customized products to cater the growing needs of the customers. Leading companies are also acquiring other companies, and enhancing their product offerings to improve their market reach. Acquisitions enable key players to increase their market potential in terms of geographic expansion and expansion of customer base.

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact us-

Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.